Entering text into the input field will update the search result below

Protagonist reports Q4 results

Mar. 07, 2017 4:35 PM ETProtagonist Therapeutics, Inc. (PTGX) StockBy: Mohit Manghnani, SA News Editor
  • Protagonist (NASDAQ:PTGX): Q4 EPS of -$0.67.
  • Cash and equivalents of $87.8M,
  • Press Release

Recommended For You

More Trending News

About PTGX Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
PTGX--
Protagonist Therapeutics, Inc.